C
Caroline H. Williams-Gray
Researcher at University of Cambridge
Publications - 123
Citations - 10894
Caroline H. Williams-Gray is an academic researcher from University of Cambridge. The author has contributed to research in topics: Parkinson's disease & Dementia. The author has an hindex of 41, co-authored 106 publications receiving 8642 citations. Previous affiliations of Caroline H. Williams-Gray include Cognition and Brain Sciences Unit & University College London.
Papers
More filters
Journal ArticleDOI
Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines
Irene Litvan,Jennifer G. Goldman,Alexander I. Tröster,Ben Schmand,Daniel Weintraub,Ronald C. Petersen,Brit Mollenhauer,Charles H. Adler,Karen Marder,Caroline H. Williams-Gray,Dag Aarsland,Jaime Kulisevsky,Maria C. Rodriguez-Oroz,David J. Burn,Roger A. Barker,Murat Emre +15 more
TL;DR: These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.
Journal ArticleDOI
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
TL;DR: This work clarifies the profile of cognitive dysfunction in early PD and demonstrates that the dementing process in this illness is heralded by both postural and gait dysfunction and cognitive deficits with a posterior cortical basis, reflecting probable non-dopaminergic cortical Lewy body pathology.
Journal ArticleDOI
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Caroline H. Williams-Gray,Jonathan R. Evans,An Goris,An Goris,Thomas Foltynie,Maria Ban,Trevor W. Robbins,Carol Brayne,Bhaskar Kolachana,Daniel R. Weinberger,Stephen Sawcer,Roger A. Barker +11 more
TL;DR: The work suggests that the dementing process in Parkinson's disease is predictable and related to tau while frontal-executive dysfunction evolves independently with a more dopaminergic basis and better prognosis.
Journal ArticleDOI
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
Dag Aarsland,Kolbjørn Brønnick,Caroline H. Williams-Gray,Daniel Weintraub,Karen Marder,Jaime Kulisevsky,David J. Burn,Paolo Barone,J. Pagonabarraga,Liesl M. Allcock,Gabriella Santangelo,Thomas Foltynie,Carmen Janvin,Jan Petter Larsen,Roger A. Barker,Murat Emre +15 more
TL;DR: Having MCI was associated with older age at assessment and at disease onset, male gender, depression, more severe motor symptoms, and advanced disease stage, and future studies of patients with PD with MCI need to determine risk factors for ongoing cognitive decline and assess interventions at a predementia stage.
Journal ArticleDOI
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Caroline H. Williams-Gray,Sarah L Mason,Jonathan R. Evans,Thomas Foltynie,Carol Brayne,Trevor W. Robbins,Roger A. Barker +6 more
TL;DR: The CamPaIGN study as mentioned in this paper has been the first to prospectively track disease evolution from diagnosis in an unselected population-representative incident cohort, focusing on three key irreversible milestones: postural instability (Hoehn and Yahr 3), dementia and death.